Picture of Immuno-Biological Laboratories logo

4570 — Immuno-Biological Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Table: Immuno Biological Lab -Q1 group results

Aug 2 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2019        Jun 30, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            113 mln             171 mln           991 mln    
                 (-34.0 pct)         (+29.4 pct)       (+27.0 pct)  
  Operating     loss 104 mln         loss 35 mln      loss 391 mln  
  Recurring     loss 127 mln         loss 35 mln      loss 550 mln  
  Net           loss 124 mln         loss 44 mln      loss 565 mln  
  EPS          loss 14.28 yen       loss 5.31 yen    loss 64.76 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T

Recent news on Immuno-Biological Laboratories

See all news